BackExelixis Overview

Exelixis Goodwill

Track Exelixis's goodwill ($64M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Goodwill
$63.68M
↑ 0.00% YoYΔ $0.00 vs prior year quarter

Peer average

Loading

Exelixis Goodwill History

Loading

Exelixis vs. peers: Goodwill Comparison

Loading

Exelixis Goodwill Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Exelixis (EXEL) FAQ

As of the most recent data (April 2026), EXEL shows a goodwill of $64M. That compares with $64M in the prior-year period — up 0.0% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, EXEL's goodwill is now $64M (was $64M) — essentially flat versus a year earlier. Pairing that YoY change with peer averages gives a clearer picture of whether Exelixis is outperforming or lagging.

Tracking EXEL's goodwill over time shows whether Exelixis is scaling, shrinking, or reshaping that part of the business. The current reading is $64M That compares with $64M in the prior-year period — up 0.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this goodwill page, Stockcircle has Exelixis's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect goodwill (currently $64M) with ownership activity and broader fundamentals.

Exelixis's goodwill is $64M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.